SCHEDULE: Asher, DBA Trading Boost Stake in Ekso Bionics

Daniel Asher and DBA Trading, LLC have reported a significant passive stake in Ekso Bionics Holdings, Inc., acquiring additional shares in late December.

Summary

• Daniel Asher and DBA Trading, LLC have filed a Schedule 13G, reporting beneficial ownership in Ekso Bionics Holdings, Inc. (EKSO).
• Daniel Asher beneficially owns 321,763 ordinary shares, representing 9.48% of the company's outstanding class.
• DBA Trading, LLC has shared voting and dispositive power over 156,763 ordinary shares, representing 4.62% of the class.
• Daniel Asher is the beneficial owner of DBA Trading, LLC and is deemed to control the share voting and dispositive power over the shares held by them.
• Recent transactions by the reporting persons include the acquisition of 134,102 shares at $9.5467 and 57,461 shares at $8.9920, and the disposition of 34,800 shares at $11.6823, all occurring in late December 2025.
• The filing explicitly states that the securities were not acquired or held for the purpose of changing or influencing the control of Ekso Bionics Holdings, Inc.

Sentiment

Score: 7

Explanation: The filing indicates a significant increase in beneficial ownership by a passive investor, suggesting confidence in Ekso Bionics' long-term prospects. While there was some profit-taking, the net effect is an increased stake, which is generally viewed positively by the market.

Positives

• Daniel Asher and DBA Trading, LLC have increased their overall stake in Ekso Bionics, indicating continued investor confidence in the company's long-term prospects.
• The net acquisition of shares in late December 2025 suggests a positive outlook on the company's valuation by these significant reporting persons.

Negatives

• A portion of shares (34,800) was sold at a higher price ($11.6823) on December 30, 2025, which could be interpreted as profit-taking by the reporting persons.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance from Ekso Bionics Holdings, Inc. or the reporting persons regarding the company's future performance or strategic direction.

Industry Context

Ekso Bionics Holdings, Inc. operates in the medical device and robotics industry, specifically focusing on powered exoskeletons for rehabilitation and industrial applications. The reported increase in a passive stake by Daniel Asher and DBA Trading, LLC suggests continued investor interest in companies within this innovative and growing sector, which is characterized by technological advancements and increasing adoption of robotic solutions in healthcare and industrial settings.

Stakeholder Impact

• Shareholders may view the increased stake by Daniel Asher and DBA Trading, LLC as a positive signal of investor confidence, potentially influencing market perception and share price.
• The company's management might interpret this as validation of their strategic direction, although the filing explicitly states no intent to influence control.

Key Dates

Keywords

Ekso Bionics, EKSO, Daniel Asher, DBA Trading, Schedule 13G, beneficial ownership, passive investment, stock acquisition, exoskeleton technology, medical devices